Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06837662 · ClinicalTrials.gov registry record · NA
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
A NA study of Opioid Dependence and Substance Abuse Disorders, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06837662 is a NA study of Opioid Dependence and Substance Abuse Disorders that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 70 participants, below the 156-participant average among 29 other Opioid Dependence trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06837662, a NA study of Opioid Dependence and Substance Abuse Disorders, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot clinical trial is to learn if a community informed designed program of addiction counseling with coordinated community peer navigator for people with Opioid Use Disorder (OUD) and other medical conditions can improve engagement in primary care and retention on buprenorphine. The main questions it aims to answer are: * Does the addition of a counseling and peer referral interventions in addition to usual primary care with low-threshold buprenorphine increase retention on medications for opioid use disorder? * Does the addition of counseling and peer referral intervention in addition to usual primary care with low-threshold buprenorphine increase engagement in primary care? Researchers will compare the MOUD "Plus" intervention compared to primary care treatment as usual low-threshold buprenorphine prescribing practice to see if MOUD "Plus" improves retention and engagement. Participants will upon screening and enrollment: * Meet with prescribers who will determine dose of buprenorphine and assess other medical issues as per treatment as usual with visits every 2-4 weeks * Meet with the integrated addictions counselor to develop rapport and support around clinic engagement, brief counseling intervention, and coordination of care in support of their MOUD * Be referred to a community based peer who meets with participants outside the clinic for support and advocacy for patient directed recovery goals * Meet with the research coordinator at 2, 3, and 6 months to complete follow-up surveys about their care and experiences
Conditions Studied
Interventions
- BEHAVIORAL MOUD "Plus" Intervention (treatment as usual + coordinated counseling and referral to community based peer)
- BEHAVIORAL Treatment As Usual (primary care with low threshold MOUD prescribing)
Study Locations (1)
Oregon
- Central City Concern - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-03-24 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06837662
The ClinicalTrials.gov registry entry for NCT06837662 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 156-participant average among 29 other Opioid Dependence trials with a reported enrollment target (55% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Opioid Dependence appearing as the primary indexed condition, and to 2 interventions - of which MOUD "Plus" Intervention (treatment as usual + coordinated counseling and referral to community based peer) is the first listed.
NCT06837662 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06837662 about?
NCT06837662 is a clinical study titled "The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care". The goal of this pilot clinical trial is to learn if a community informed designed program of addiction counseling with coordinated community peer navigator for people with Opioid Use Disorder (OUD) and other medical conditions can improve engagement in primary care and retention on buprenorphine. ...
What is the current status of trial NCT06837662?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-03-24. Estimated completion is 2026-12-01.
What conditions does trial NCT06837662 study?
This clinical trial studies the following conditions: Opioid Dependence, Substance Abuse Disorders, Complex Medical Patients, Primary Care Patients With Chronic Conditions.
What interventions are being tested in trial NCT06837662?
The interventions under investigation include: MOUD "Plus" Intervention (treatment as usual + coordinated counseling and referral to community based peer) (BEHAVIORAL), Treatment As Usual (primary care with low threshold MOUD prescribing) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06837662?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06837662 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder
ACTIVE NOT RECRUITING · NA
-
Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
COMPLETED · NA
-
Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments
COMPLETED · NA
-
fMRI and Opioid Abstinence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.